Table 3.
Overall | no-AKI_no-DM | no-AKI_DM | AKI_ no-DM | AKI_DM | p * | p ** | |
30-day outcomes | |||||||
Major adverse cardiac events | 2376 (14.1) | 1221 (11.9) | 744 (13.4) | 202 (40.3) | 209 (40.8) | 0.92 | <0.001 |
mortality | 805 (4.8) | 290 (2.8) | 227 (4.1) | 148 (29.7) | 140 (27.4) | 0.45 | <0.001 |
re-hospitalization | 2868 (18.9) | 1697 (18.1) | 1001 (19.9) | 83 (23.4) | 87 (23.8) | 0.99 | 0.09 |
reinfarction | 286 (1.9) | 150 (1.7) | 92 (1.8) | 21 (5.0) | 23 (5.2) | 1 | <0.001 |
Angina | 322 (4.0) | 189 (3.9) | 123 (4.3) | 5 (3.6) | 5 (2.8) | 0.91 | 0.4 |
CABG | 1397 (8.4) | 785 (7.8) | 556 (10.1) | 30 (6.0) | 26 (5.2) | 0.69 | <0.001 |
1-year outcomes | |||||||
mortality | 1580 (9.6) | 597 (6.0) | 540 (10.0) | 222 (44.8) | 221 (43.7) | 0.78 | <0.001 |
CABG: coronary artery bypass graft surgery. * p for comparison between the following groups: AKI_ DM vs. AKI_no-DM (comparison between diabetic patients with AKI vs. non-diabetic patients that developed AKI). ** p for comparison between the following groups: AKI_DM vs. no-AKI_DM (comparison between diabetic patients with AKI vs. diabetic patients that did not develop AKI.).